Inkster, Becky <br/><br/>
GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?  [electronic resource] 

 -  Translational psychiatry  10 2018 
 - 216 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>2158-3188 
<br/><br/><label>Standard No.: </label>10.1038/s41398-018-0270-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cognition--drug effects<br/>Erythropoietin--administration & dosage<br/>Glycogen Synthase Kinase 3 beta--metabolism<br/>Hippocampus--drug effects<br/>Humans<br/>Mood Disorders--drug therapy<br/>Neuroprotective Agents--administration & dosage